Abstract:The recent remarkable success and safety of mRNA lipid nanoparticle technology for producing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines has stimulated intensive efforts to expand nano -particle strategies to treat various diseases. Numerous synthetic nanoparticles have been developed for phar-maceutical delivery and cancer treatment. However, only a limited number of nanotherapies have enter clinical trials or are clinically approved. Systemically administered nanotherapies are likely to be sequestered by host mononuclear phagocyte system (MPS), resulting in suboptimal pharmacokinetics and insufficient drug concen-trations in tumors. Bioinspired drug-delivery formulations have emerged as an alternative approach to evade the MPS and show potential to improve drug therapeutic efficacy. Here we developed a biodegradable polymer -conjugated camptothecin prodrug encapsulated in the plasma membrane of lipopolysaccharide-stimulated macrophages. Polymer conjugation revived the parent camptothecin agent (e.g., 7-ethyl-10-hydroxy-camptothe-cin), enabling lipid nanoparticle encapsulation. Furthermore, macrophage membrane cloaking transformed the nonadhesive lipid nanoparticles into bioadhesive nanocamptothecin, increasing the cellular uptake and tumor -tropic effects of this biomimetic therapy. When tested in a preclinical murine model of breast cancer, macrophage-camouflaged nanocamptothecin exhibited a higher level of tumor accumulation than uncoated nanoparticles. Furthermore, intravenous administration of the therapy effectively suppressed tumor growth and the metastatic burden without causing systematic toxicity. Our study describes a combinatorial strategy that uses polymeric prodrug design and cell membrane cloaking to achieve therapeutics with high efficacy and low toxicity. This approach might also be generally applicable to formulate other therapeutic candidates that are not compatible or miscible with biomimetic delivery carriers.

Macrophage membrane coated discoidal polymeric particles for evading phagocytosis

Effect of partial PEGylation on particle uptake by macrophages.

Half Pegylated Particles Evade Macrophages As Effectively As Fully Pegylated Ones

Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells.

Preparation and characterization of macrophage membrane camouflaged cubosomes as a stabilized and immune evasive biomimetic nano-DDS

Polymeric coating lubricates nanocontainers to escape macrophage uptake for bioreceptor recognition

Cyclodextrin-Based Star-Like Amphiphilic Cationic Polymer As a Potential Pharmaceutical Carrier in Macrophages

Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells

Body Distribution and in Situ Evading of Phagocytic Uptake by Macrophages of Long-Circulating Poly (ethylene Glycol) Cyanoacrylate-Co-n-hexadecyl Cyanoacrylate Nanoparticles.

Macrophage membrane-coated Eucommia ulmoides polysaccharides-loaded PLGA nanoparticles as an effective antigen-targeted delivery system

Anti-phagocytosis and tumor cell targeting micelles prepared from multifunctional cell membrane mimetic polymers

Evasion of opsonization of macromolecules using novel surface-modification and biological-camouflage-mediated techniques for next-generation drug delivery

Macrophage membrane-biomimetic adhesive polycaprolactone nanocamptothecin for improving cancer-targeting efficiency and impairing metastasis

Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy.

Stable, Bioresponsive, and Macrophage-Evading Polyurethane Micelles Containing an Anionic Tripeptide Chain Extender

Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment

Nanomedicine engulfed by macrophages for targeted tumor therapy

Targeted Gene Delivery to Macrophages by Biodegradable Star-Shaped Polymers.

Ph-Responsive Polymersome Based on PMCP-b-PDPA As a Drug Delivery System to Enhance Cellular Internalization and Intracellular Drug Release

Polyglycerol Grafting Shields Nanoparticles from Protein Corona Formation to Avoid Macrophage Uptake

Oriented Assembly of Cell-Mimicking Nanoparticles via a Molecular Affinity Strategy for Targeted Drug Delivery.